Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Hou, Xinwei ^a   Sun, Liang ^a   Li, Zongmeng ^a   Mou, Haiwei ^a   Yu, Zhijie ^a   Li, Huaixing ^a   Jiang, Peizhen ^b   Yu, Danxia ^a   Wu, Hongyu ^a   Ye, Xingwang ^a   Lin, Xu ^a   Le, Yingying ^a  

^a Chinese Academy of Sciences   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LIPID; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERAMYLINEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE; ASIAN; BLOOD; INFLAMMATION; METABOLISM; MIDDLE AGED;

ANIMALIA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-6; ISLET AMYLOID POLYPEPTIDE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT;

EID: 80052842910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024815     Document Type: Article

References (37)

1. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, et al. (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84: 8628-8632.
2. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH, (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414-417.
3. Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, et al. (1990) Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39: 639-642.
4. Qi D, Cai K, Wang O, Li Z, Chen J, et al. (2010) Fatty acids induce amylin expression and secretion by pancreatic beta-cells. Am J Physiol Endocrinol Metab 298: E99-E107.
5. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, et al. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756.
6. Lutz TA, (2010) The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol 298: R1475-1484.
7. Lutz TA, (2006) Amylinergic control of food intake. Physiol Behav 89: 465-471.
8. Wielinga PY, Lowenstein C, Muff S, Munz M, Woods SC, et al. (2010) Central amylin acts as an adiposity signal to control body weight and energy expenditure. Physiol Behav 101: 45-52.
9. Leighton B, Cooper GJ, (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635.
10. Ciaraldi TP, Goldberg M, Odom R, Stolpe M, (1992) In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes 41: 975-981.
11. Matveyenko AV, Butler PC, (2006) Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55: 2106-2114.
12. Sowa R, Sanke T, Hirayama J, Tabata H, Furuta H, et al. (1990) Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118-120.
13. Reinehr T, de Sousa G, Niklowitz P, Roth CL, (2007) Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity 15: 2006-2011.
14. Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, et al. (1991) Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 129-132.
15. James S, Moralez J, Nagamani M, (2010) Increased secretion of amylin in women with polycystic ovary syndrome. Fertil Steril 94: 211-215.
16. Kairamkonda VR, Deorukhkar A, Bruce C, Coombs R, Fraser R, et al. (2008) Amylin peptide is increased in preterm neonates with feed intolerance. Arch Dis Child Fetal Neonatal Ed 93: F265-270.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
18. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132.
19. Ford ES, Giles WH, Dietz WH, (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359.
20. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. The Lancet 365: 1398-1405.
21. Tataranni PA, Ortega E, (2005) A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54: 917-927.
22. Sun L, Yu Z, Ye X, Zou S, Li H, et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33: 1925-1932.
23. Zhou BF, (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83-96.
24. Zhou BF, (2002) Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci 15: 245-252.
25. Chen C, Lu FC, (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17 (Suppl): 1-36.
26. Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, et al. (1992) Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15: 89-96.
27. Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, et al. (1992) Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15: 97-102.
28. Despres J-P, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
29. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, et al. (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25: 2016-2021.
30. Ye X, Yu Z, Li H, Franco OH, Liu Y, et al. (2007) Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49: 1798-1805.
31. O'Brien TD, Westermark P, Johnson KH, (1991) Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 40: 1701-1706.
32. Leckström A, Ostenson CG, Efendić S, Arnelo U, Permert J, et al. (1996) Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat. Pancreas 13: 259-267.
33. Cai K, Qi D, Wang O, Chen J, Liu X, et al. (2011) TNF-alpha acutely upregulates amylin expression in murine pancreatic beta cells. Diabetologia 54: 617-626.
34. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11: 897-904.
35. Denke MA, Sempos CT, Grundy SM, (1993) Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 153: 1093-1103.
36. Smith D, Mamo JC, (2000) Islet amyloid polypeptide (amylin) modulates chylomicron metabolism in rats. Clin Exp Pharmacol Physiol 27: 345-351.
37. Ye JM, Lim-Fraser M, Cooney GJ, Cooper GJ, Iglesias MA, et al. (2001) Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. Am J Physiol Endocrinol Metab 280: E562-569.